Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Microbiota of the Hickey Run Tributary of the Anacostia River.

Cagle R, Ramachandran P, Reed E, Commichaux S, Mammel MK, Lacher DW, Miller D, Lindley S, Pop M, Bazaco MC, Wolpert B, Strain EA, Aker S, Feely J, Ottesen A.

Microbiol Resour Announc. 2019 Mar 21;8(12). pii: e00123-19. doi: 10.1128/MRA.00123-19.

2.

A survey of patients' attitudes to clinical research.

Desmond A, Stanton A, Maher V, Crean P, Feely J, Sullivan P.

Ir Med J. 2011 Apr;104(4):117-9.

PMID:
21675095
3.

Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.

Gitt AK, Drexel H, Feely J, Ferrières J, Gonzalez-Juanatey JR, Thomsen KK, Leiter LA, Lundman P, da Silva PM, Pedersen T, Wood D, Jünger C, Dellea PS, Sazonov V, Chazelle F, Kastelein JJ; DYSIS Investigators.

Eur J Prev Cardiol. 2012 Apr;19(2):221-30. doi: 10.1177/1741826711400545. Epub 2011 Mar 10.

PMID:
21450578
4.

Prevalence of dyslipidaemia in statin-treated patients in Ireland: Irish results of the DYSlipidaemia International Study (DYSIS).

Horgan S, Crowley J, Feely J, McAdam B, Shanahan E, Vaughan C.

Ir J Med Sci. 2011 Jun;180(2):343-9. doi: 10.1007/s11845-011-0702-8. Epub 2011 Mar 13.

PMID:
21400212
5.

Prevalence of renal artery stenosis in flash pulmonary oedema: determination using gadolinium-enhanced MRA.

McMahon CJ, Hennessy M, Boyle G, Feely J, Meaney JF.

Eur J Intern Med. 2010 Oct;21(5):424-8. doi: 10.1016/j.ejim.2010.04.003. Epub 2010 May 18.

PMID:
20816598
6.

Potentially inappropriate prescribing and cost outcomes for older people: a national population study.

Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K.

Br J Clin Pharmacol. 2010 May;69(5):543-52. doi: 10.1111/j.1365-2125.2010.03628.x.

7.

A competing risks prescription refill model of compliance and persistence.

Barron TI, Bennett K, Feely J.

Value Health. 2010 Sep-Oct;13(6):796-804. doi: 10.1111/j.1524-4733.2010.00741.x. Epub 2010 Jun 7.

8.

Ventricular activation time as a marker for diastolic dysfunction in early hypertension.

Boles U, Almuntaser I, Brown A, Murphy RR, Mahmud A, Feely J.

Am J Hypertens. 2010 Jul;23(7):781-5. doi: 10.1038/ajh.2010.58. Epub 2010 Mar 25.

PMID:
20339351
9.

Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries.

Hermans MP, Castro Cabezas M, Strandberg T, Ferrières J, Feely J, Elisaf M, Michel G, Sansoy V.

Curr Med Res Opin. 2010 Feb;26(2):445-54. doi: 10.1185/03007990903500565.

PMID:
20001658
10.

Hypertension in Ireland: public awareness and doctors choice of therapy.

Zaharan NL, Mahmud A, Bennett K, Feely J.

Ir J Med Sci. 2009 Dec;178(4):413-7. doi: 10.1007/s11845-009-0367-8. Epub 2009 Oct 17.

PMID:
19838641
11.

Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques.

Jatoi NA, Mahmud A, Bennett K, Feely J.

J Hypertens. 2009 Nov;27(11):2186-91. doi: 10.1097/HJH.0b013e32833057e8.

PMID:
19834344
12.

A RCT evaluating the effectiveness and cost-effectiveness of academic detailing versus postal prescribing feedback in changing GP antibiotic prescribing.

Naughton C, Feely J, Bennett K.

J Eval Clin Pract. 2009 Oct;15(5):807-12. doi: 10.1111/j.1365-2753.2008.01099.x.

PMID:
19811593
13.

Blood pressure control determines improvement in diastolic dysfunction in early hypertension.

Almuntaser I, Mahmud A, Brown A, Murphy R, King G, Crean P, Feely J.

Am J Hypertens. 2009 Nov;22(11):1227-31. doi: 10.1038/ajh.2009.173. Epub 2009 Sep 17.

PMID:
19763121
14.

Left ventricular structural and functional changes in the metabolic syndrome.

Mahmud A, Almuntaser I, Brown A, King G, Crean P, Feely J.

J Cardiometab Syndr. 2009 Spring;4(2):81-8. doi: 10.1111/j.1559-4572.2008.00043.x.

15.

EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results.

Cooney MT, Storey S, Taylor L, Dudina A, Hall M, Hemeryck L, Feely J, Graham I.

Ir Med J. 2009 Apr;102(4):113-6.

PMID:
19552291
16.

Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement database.

Canavan JB, Bennett K, Feely J, O'Moráin CA, O'Connor HJ.

Aliment Pharmacol Ther. 2009 Feb 15;29(4):440-9. doi: 10.1111/j.1365-2036.2008.03893.x. Epub 2008 Nov 14.

17.

Anti-depressants in primary care: analysis of treatment discontinuations.

McGettigan P, Kelly A, Carvahlo M, Feely J.

Pharmacoepidemiol Drug Saf. 2000 Nov;9(6):521-8. doi: 10.1002/1099-1557(200011)9:6<521::AID-PDS525>3.0.CO;2-K.

PMID:
19025858
18.

Influence of media and regulatory changes on prescribing of cotrimoxazole and trimethoprim in Ireland.

Williams D, Kelly A, Feely J.

Pharmacoepidemiol Drug Saf. 2000 Jul;9(4):313-7. doi: 10.1002/1099-1557(200007/08)9:4<313::AID-PDS508>3.0.CO;2-F.

PMID:
19025834
19.

Choice of first antihypertensive - are existing guidelines ignored? Response to Vegter & de Jong-van den Berg.

Okechukwu I, Mahmud A, Bennett K, Feely J.

Br J Clin Pharmacol. 2008 Oct;66(4):561. doi: 10.1111/j.1365-2125.2008.03182.x. No abstract available.

20.

Epidemiology and economics of statin use.

Feely J, Bennett K.

Ir Med J. 2008 Jun;101(6):188-91.

PMID:
18705057
21.

Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.

Mahmud A, Feely J.

Am J Hypertens. 2008 Jun;21(6):663-7. doi: 10.1038/ajh.2008.156. Epub 2008 Apr 10.

PMID:
18437130
22.

A review of studies of adherence with antihypertensive drugs using prescription databases.

Fitz-Simon N, Bennett K, Feely J.

Ther Clin Risk Manag. 2005 Jun;1(2):93-106.

23.

Ambulatory arterial stiffness index, pulse wave velocity and augmentation index--interchangeable or mutually exclusive measures?

Jerrard-Dunne P, Mahmud A, Feely J.

J Hypertens. 2008 Mar;26(3):529-34. doi: 10.1097/HJH.0b013e3282f35265.

PMID:
18300865
25.

Comparison of echocardiographic measures of left ventricular diastolic function in early hypertension.

Almuntaser I, Brown A, Murphy R, Crean P, King G, Mahmud A, Feely J.

Am J Cardiol. 2007 Dec 15;100(12):1771-5.

PMID:
18082524
26.

Choice of first antihypertensive--are existing guidelines ignored?

Okechukwu I, Mahmud A, Bennett K, Feely J.

Br J Clin Pharmacol. 2007 Dec;64(6):722-5. Epub 2007 Oct 22. Review.

27.

Choice of first antihypertensive: simple as ABCD?

Mahmud A, Feely J.

Am J Hypertens. 2007 Aug;20(8):923-7.

PMID:
17679044
28.
29.

Primary care prescribing patterns in Ireland after the publication of large hypertension trials.

Kabir Z, Feely J, Bennett K.

Br J Clin Pharmacol. 2007 Sep;64(3):381-5. Epub 2007 Jul 4.

30.

Spironolactone in resistant hypertension.

Feely J, Mahmud A.

Hypertension. 2007 Sep;50(3):e57; author reply e58. Epub 2007 Jul 2. No abstract available.

PMID:
17606857
31.

An HPLC method for the determination of the free cortisol/cortisone ratio in human urine.

Al Sharef O, Feely J, Kavanagh PV, Scott KR, Sharma SC.

Biomed Chromatogr. 2007 Nov;21(11):1201-6.

PMID:
17590867
32.

Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension.

Zhou S, Feely J, Spiers JP, Mahmud A.

J Hum Hypertens. 2007 Nov;21(11):861-7. Epub 2007 Jun 21.

PMID:
17581602
33.

Circadian blood pressure variation: relationship between dipper status and measures of arterial stiffness.

Jerrard-Dunne P, Mahmud A, Feely J.

J Hypertens. 2007 Jun;25(6):1233-9.

PMID:
17563536
34.

What therapies have replaced rofecoxib in Ireland?

Teeling M, O'Connor H, Feely J, Bennett K.

Br J Clin Pharmacol. 2007 Oct;64(4):536-41. Epub 2007 Jun 6.

35.

National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.

Mahmud A, Bennett K, Okechukwu I, Feely J.

Br J Clin Pharmacol. 2007 Nov;64(5):706-9. Epub 2007 Jun 6.

36.

An evaluation of the effects of renal artery stenting in renovascular hypertension.

Mak G, Tan CY, Ben Khiaron O, McEniff N, Feely J.

Ir Med J. 2007 Mar;100(3):397-8.

PMID:
17491539
37.

Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension.

Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A.

Hypertension. 2007 May;49(5):981-5. Epub 2007 Mar 19. Erratum in: Hypertension. 2007 Jul;50(1):e11.

PMID:
17372029
38.

Influence of the G-protein beta-3 subunit gene C825 T polymorphism on the clinical phenotype of newly diagnosed essential hypertension.

Jerrard-Dunne P, Mahmud A, Zhou S, Feely J.

J Hum Hypertens. 2007 May;21(5):421-3. Epub 2007 Mar 1. No abstract available.

PMID:
17330058
39.

Advanced glycation end-products and arterial stiffness in hypertension.

McNulty M, Mahmud A, Feely J.

Am J Hypertens. 2007 Mar;20(3):242-7.

PMID:
17324733
40.

Early discontinuation of tamoxifen: a lesson for oncologists.

Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ.

Cancer. 2007 Mar 1;109(5):832-9.

41.

Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.

Mahmud A, Feely J.

Hypertension. 2007 Feb;49(2):272-5. Epub 2006 Dec 18.

PMID:
17178976
42.

Impact of high dose statin trials on hospital prescribers.

Barron TI, Bennett K, Feely J.

Eur J Clin Pharmacol. 2007 Jan;63(1):65-72. Epub 2006 Nov 18.

PMID:
17115149
43.
44.

Acute haemodynamic effects of cigarette smoking in healthy young subjects.

Zamir Z, Mahmud A, Feely J.

Ir J Med Sci. 2006 Jul-Sep;175(3):20-3.

PMID:
17073242
45.

Characterizing new users of NSAIDs before and after rofecoxib withdrawal.

Usher C, Bennett K, Teeling M, Feely J.

Br J Clin Pharmacol. 2007 Apr;63(4):494-7. Epub 2006 Oct 19.

46.

Prevalence of chronic disease in the elderly based on a national pharmacy claims database.

Naughton C, Bennett K, Feely J.

Age Ageing. 2006 Nov;35(6):633-6. No abstract available.

PMID:
17047009
47.

Prescribing for patients with diabetes in the community drug schemes.

Usher C, Creed L, Bennett K, Feely J.

Ir Med J. 2006 Jun;99(6):181-3.

PMID:
16921826
48.

Impact of Helicobacter pylori on the management of dyspepsia in primary care.

Bennett K, Feely J, Thornton O, Dobson M, O'Morain CA, O'Connor HJ.

Aliment Pharmacol Ther. 2006 Aug 15;24(4):637-41.

49.

Adherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillation.

Savage M, Teeling M, Bennett K, Feely J.

Ir J Med Sci. 2006 Apr-Jun;175(2):46-9.

PMID:
16872029
50.

The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.

Kabir Z, Bennett K, Shelley E, Unal B, Critchley J, Feely J, Capewell S.

QJM. 2006 Aug;99(8):523-30. Epub 2006 Jul 22.

PMID:
16861717

Supplemental Content

Support Center